ARTICLE | Clinical News
HCT-3012: Began Phase II testing
January 29, 2001 8:00 AM UTC
NicOx S.A. (NM:Nicox), Sophia-Antipolis, France Product: HCT-3012 Business: Autoimmune/Inflammation Therapeutic category: NSAID, Nitric oxide Target: Cyclooxygenase (COX) enzymes Description: Nitric o...